GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » Pre-Tax Income

TTY Biopharm Co (ROCO:4105) Pre-Tax Income : NT$1,886 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. TTY Biopharm Co's pretax income for the three months ended in Dec. 2024 was NT$669 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was NT$1,886 Mil. TTY Biopharm Co's pretax margin was 39.05%.

During the past 13 years, TTY Biopharm Co's highest Pretax Margin was 47.75%. The lowest was 23.97%. And the median was 30.23%.


TTY Biopharm Co Pre-Tax Income Historical Data

The historical data trend for TTY Biopharm Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co Pre-Tax Income Chart

TTY Biopharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,201.53 1,087.38 1,408.34 1,419.47 1,885.69

TTY Biopharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 227.04 368.05 349.52 499.57 668.55

Competitive Comparison of TTY Biopharm Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTY Biopharm Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Pre-Tax Income falls into.


;
;

TTY Biopharm Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

TTY Biopharm Co's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=1393.782+0+-38.739+85.76+444.884
=1,886

TTY Biopharm Co's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=343.218+0+-10.325+23.996+311.663
=669

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,886 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TTY Biopharm Co  (ROCO:4105) Pre-Tax Income Explanation

TTY Biopharm Co's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=668.552/1712.127
=39.05%

During the past 13 years, TTY Biopharm Co's highest Pretax Margin was 47.75%. The lowest was 23.97%. And the median was 30.23%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TTY Biopharm Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


TTY Biopharm Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co Headlines

No Headlines